Skip to main content
Fig. 4 | Annals of Intensive Care

Fig. 4

From: Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality

Fig. 4

Kaplan–Meier curves in patients with sRAGE levels < 5833 pg/ml or ≥ 5833 pg/ml. Patients with sRAGE levels ≥ 5833 pg/mL showed significantly higher risk of mortality than those with sRAGE levels < 5833 pg/mL with a hazard ratio of 38.68 (8.33–179.7), p < 0.001. sRAGE: soluble receptor for advanced glycation end products

Back to article page